Turn to Tapentadol in a Post-Oxycodone World?

Commentary
par
McAnally, Health

Date de publication

2022

Géographie

USA

Langue de la ressource

English

Texte disponible en version intégrale

Oui

Open Access / OK to Reproduce

Non

Évalué par des pairs

No

Constatations/points à retenir

Tapentadol (Nucynta), a tramadol analog, is a weak opioid agonist (1/18th of the potency of morphine in terms of mu-opioid receptor binding/activation), but in concert with norepinephrine reuptake inhibition (NRI) it yields significantly synergistically increased analgesic efficacy, as well as reduced tolerance and reduced adverse effect profile.

Mots clés

Chronic pain